X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS BIOCON LTD DR. DATSONS LABS/
BIOCON LTD
 
P/E (TTM) x -10.9 78.0 - View Chart
P/BV x 0.2 7.3 2.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   BIOCON LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
BIOCON LTD
Mar-17
DR. DATSONS LABS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1261,162 10.8%   
Low Rs31483 6.4%   
Sales per share (Unadj.) Rs133.0194.6 68.4%  
Earnings per share (Unadj.) Rs0.234.4 0.4%  
Cash flow per share (Unadj.) Rs6.648.3 13.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs128.8241.9 53.2%  
Shares outstanding (eoy) m31.66200.00 15.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.2 13.9%   
Avg P/E ratio x516.123.9 2,159.7%  
P/CF ratio (eoy) x11.817.0 69.5%  
Price / Book Value ratio x0.63.4 17.9%  
Dividend payout %02.9 0.0%   
Avg Mkt Cap Rs m2,477164,440 1.5%   
No. of employees `000NA9.2 0.0%   
Total wages/salary Rs m567,470 0.7%   
Avg. sales/employee Rs ThNM4,213.9-  
Avg. wages/employee Rs ThNM809.0-  
Avg. net profit/employee Rs ThNM745.2-  
INCOME DATA
Net Sales Rs m4,21138,911 10.8%  
Other income Rs m791,571 5.0%   
Total revenues Rs m4,28940,482 10.6%   
Gross profit Rs m5699,795 5.8%  
Depreciation Rs m2042,772 7.4%   
Interest Rs m430260 165.5%   
Profit before tax Rs m138,334 0.2%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,616 0.4%   
Profit after tax Rs m56,881 0.1%  
Gross profit margin %13.525.2 53.6%  
Effective tax rate %48.019.4 247.7%   
Net profit margin %0.117.7 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85240,477 16.9%   
Current liabilities Rs m6,71116,783 40.0%   
Net working cap to sales %3.360.9 5.5%  
Current ratio x1.02.4 42.3%  
Inventory Days Days16160 269.9%  
Debtors Days Days31883 384.4%  
Net fixed assets Rs m3,67345,073 8.1%   
Share capital Rs m3171,000 31.7%   
"Free" reserves Rs m3,76147,377 7.9%   
Net worth Rs m4,07848,377 8.4%   
Long term debt Rs m1,67121,082 7.9%   
Total assets Rs m12,63393,942 13.4%  
Interest coverage x1.033.1 3.1%   
Debt to equity ratio x0.40.4 94.0%  
Sales to assets ratio x0.30.4 80.5%   
Return on assets %3.47.6 45.3%  
Return on equity %0.114.2 0.8%  
Return on capital %7.712.6 60.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96412,988 7.4%   
Fx outflow Rs m6077,899 7.7%   
Net fx Rs m3575,089 7.0%   
CASH FLOW
From Operations Rs m1,3456,400 21.0%  
From Investments Rs m-2,256-4,985 45.2%  
From Financial Activity Rs m-1,200-1,775 67.6%  
Net Cashflow Rs m-2,111-473 446.2%  

Share Holding

Indian Promoters % 4.5 40.4 11.2%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.0 8.4 -  
FIIs % 1.4 10.7 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 19.9 472.9%  
Shareholders   20,807 109,995 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - TTK HEALTHCARE COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS